Flavonoids as multi-target compounds: A special emphasis on their potential as chemo-adjuvants in cancer therapy

Ajay G. Namdeo, Sai H.S. Boddu, Haneen Amawi, Charles R. Ashby, Diwakar B. Tukaramrao, Piyush Trivedi, R. Jayachandra Babu, Amit K. Tiwari

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Abstract

Flavonoids are low molecular weight, polyphenolic phytochemicals, obtained from secondary metabolism of various plant compounds. They have a spectrum of pharmacological efficacies, including potential anti-cancer efficacy. Natural flavonoids are present in fruits, vegetables, grains, bark, roots, stems, flowers, tea and wine. Flavonoids can attenuate or inhibit the initiation, promotion and progression of cancer by modulating various enzymes and receptors in diverse pathways that involve cellular proliferation, differentiation, apoptosis, in-flammation, angiogenesis and metastasis. Furthermore, in vitro, flavonoids have been shown to reverse multidrug resistance when used as chemo-adjuvants. Flavonoids (both natural and synthetic analogues) interact with several oncogenic targets through dependent and independent mechanisms to mediate their anticancer efficacy in different types of cancer cells.

Original languageEnglish (US)
Pages (from-to)1712-1728
Number of pages17
JournalCurrent Pharmaceutical Design
Volume26
Issue number15
DOIs
StatePublished - 2020

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this